<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/tmiv-imaging-launches-clarion-ct-system-india</loc>
    <lastmod>2026-08-29T18:08:28+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>TMIV Imaging Launches AI-Driven CLARION CT in India</news:title>
      <news:keywords>TMIV</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d8c23c42-f7cb-41fc-9911-45a54aa19293/9856a5a5-f0d0-45ad-8690-4deb385c48d7.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/evonik-invests-c150-million-vancouver-facility-triple-advanced-pharma-manufacturing-capacity</loc>
    <lastmod>2026-08-29T18:11:04+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>Evonik Invests C$150M to Triple Vancouver Pharma Capacity</news:title>
      <news:keywords>Evonik</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d8c23c42-f7cb-41fc-9911-45a54aa19293/de56f684-10f6-4915-9224-329f44d1ed1a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-first-targeted-therapy-metastatic-pancreatic-adenocarcinoma-approval</loc>
    <lastmod>2026-08-29T18:03:11+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Approves First Targeted Therapy for Metastatic Pancreatic Cancer</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d8c23c42-f7cb-41fc-9911-45a54aa19293/c9eadd75-2b29-4391-9e87-48f33ca1b777.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/lilly-fda-approval-mounjaro-cardiovascular-risk-type-2-diabetes</loc>
    <lastmod>2026-08-29T18:00:15+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>Lilly Wins FDA Nod for Mounjaro Cardiovascular Benefit</news:title>
      <news:keywords>Lilly</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d8c23c42-f7cb-41fc-9911-45a54aa19293/50e62b23-2e61-4fe2-8e9e-603c810135c9.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cipla-pune-drug-sale-licence-cancellation-maharashtra-fda-reactin-plus</loc>
    <lastmod>2026-08-29T16:07:25+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>Cipla's Pune Unit Loses Drug Licence Over Reactin Plus Issue</news:title>
      <news:keywords>Cipla</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/13e01f04-403e-463f-87f2-9863ba1902b7/81b3f7bb-6ee0-46c2-bfb7-f0a9ea117fc5.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/janssen-fda-approval-stelara-pediatric-ulcerative-colitis</loc>
    <lastmod>2026-08-29T16:06:48+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Approves Janssen's Stelara for Pediatric Colitis Use</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/13e01f04-403e-463f-87f2-9863ba1902b7/b8248116-8dde-4b25-89a6-5b1bdd9b7938.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/takeda-fda-approval-mimrylo-rusfertide-polycythemia-vera</loc>
    <lastmod>2026-08-29T16:06:07+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>Takeda's Mimrylo Gains FDA Approval for Polycythemia Vera</news:title>
      <news:keywords>Takeda</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/80c9a5f6-bd21-495b-8dbc-40bf34017dab/5d8fa580-41ce-48a5-ac2f-15e399b8e905.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-isop-workshop-model-informed-dosage-optimization-oncology-combination-therapies</loc>
    <lastmod>2026-08-29T11:40:26+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA, ISoP Workshop Targets Oncology Dosage Optimization</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6e29409f-c71c-42e7-a336-f53427c6c5f9/d9c3e190-be02-4629-a6a5-365994c79f3f.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-pda-33rd-joint-regulatory-conference-cgmp-quality-systems-september-2024</loc>
    <lastmod>2026-08-29T16:07:46+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA, PDA Host 33rd Joint Conference on CGMP Quality</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6e29409f-c71c-42e7-a336-f53427c6c5f9/80b2fc50-42d7-43f2-8cb7-a2da27710485.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-workshop-pbpk-absorption-modeling-bioequivalence-regulatory-tool-2023</loc>
    <lastmod>2026-08-29T11:42:14+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Workshop Advances PBPK Modeling for Bioequivalence</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6e29409f-c71c-42e7-a336-f53427c6c5f9/3abb7e3c-b4dc-4704-9f66-c8ff8c2939f1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/abbvie-ema-submission-subcutaneous-skyrizi-crohns-disease</loc>
    <lastmod>2026-08-28T22:46:05+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>AbbVie Files EMA Bid for Subcutaneous SKYRIZI in Crohn’s</news:title>
      <news:keywords>AbbVie</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d53564a9-1e3b-44f0-8f67-4f2cda3f7c39/c2860d9a-ab07-413d-9952-f9866713cd64.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-cder-withdrawn-product-specific-guidances-august-2026</loc>
    <lastmod>2026-08-28T22:49:02+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Updates Withdrawn Product-Specific Guidance List</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d53564a9-1e3b-44f0-8f67-4f2cda3f7c39/198c2d33-0443-4379-925c-44cf11c5198a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cdt-equity-validates-enhanced-solid-form-properties-ai-crystal-structure</loc>
    <lastmod>2026-08-28T22:47:42+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>CDT Equity Validates AI-Driven Crystal Structures for Drugs</news:title>
      <news:keywords>CDT</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d53564a9-1e3b-44f0-8f67-4f2cda3f7c39/f5124592-2106-400e-8e3f-105b30cfca1a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/b-braun-medical-recalls-sodium-chloride-injection-zinc-oxide-particulate</loc>
    <lastmod>2026-08-28T22:50:26+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>B. Braun Recalls Sodium Chloride Lots Over Zinc Oxide</news:title>
      <news:keywords>B. Braun</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d53564a9-1e3b-44f0-8f67-4f2cda3f7c39/bf5e692c-ec4d-4235-bc7c-79d1690d2cbc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/teva-acquires-bioxcel-dexmedetomidine-sublingual-film-bankruptcy-court-bid</loc>
    <lastmod>2026-08-28T22:44:33+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Teva Bids $125M for BioXcel’s IGALMI in Bankruptcy Sale</news:title>
      <news:keywords>Teva</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml-eu.globenewswire.com/Resource/Download/68cd1f4d-02f6-4b28-8723-30ad8605f8b5</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/celularity-musecell-innovations-us-manufacturing-collaboration-dezawa-musecell</loc>
    <lastmod>2026-08-28T11:37:40+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Celularity Signs U.S. Deal with MuseCell for Dezawa Cells</news:title>
      <news:keywords>Celularity</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://s.w.org/images/core/emoji/17.0.2/72x72/2122.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-warns-compounders-dietary-supplement-glutathione-injectable-adverse-events</loc>
    <lastmod>2026-08-28T11:39:48+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Warns Compounders on Glutathione After 30 Adverse Events</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0874ea77-dd7c-4243-b0f8-8fd9ad152269/1f591490-b0d1-49cb-a8d7-2b7e13cb3b3e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-extends-use-dates-hospira-baxter-injectable-lots-drug-shortages</loc>
    <lastmod>2026-08-28T11:41:41+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Extends Use Dates on Hospira, Baxter Vials Amid Shortages</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0874ea77-dd7c-4243-b0f8-8fd9ad152269/f1208e94-f058-4e32-ab46-4981ac2e32dd.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sanofi-vaccines-canada-fda-supplemental-approval-daptacel-dtap</loc>
    <lastmod>2026-08-28T11:37:57+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Sanofi Vaccines Wins FDA Nod for DAPTACEL DTaP Biologics License</news:title>
      <news:keywords>Sanofi</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0874ea77-dd7c-4243-b0f8-8fd9ad152269/8afa982d-dea2-4028-918d-7f5410bbb241.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/roivant-fda-approval-brepocitinib-lisraya-dermatomyositis</loc>
    <lastmod>2026-08-28T11:37:46+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Roivant Wins a First FDA Nod for Brepocitinib in Dermatomyositis</news:title>
      <news:keywords>Roivant</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/Resource/Download/c822a26b-5df5-41c7-9018-13a195ea1f51</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/priovant-fda-approval-brepocitinib-lisraya-dermatomyositis</loc>
    <lastmod>2026-08-28T11:37:58+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T00:00:00+05:30</news:publication_date>
      <news:title>Priovant Wins a First FDA Nod for Brepocitinib in Dermatomyositis</news:title>
      <news:keywords>Priovant</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/Resource/Download/4c9c8a80-2004-4328-82df-68a3d9e233f1</image:loc>
    </image:image>
  </url>
</urlset>